Oculus Innovative Sciences to Present at OneMed Forum 2011 During JP Morgan Week in San Francisco
Presentation and Live Webcast on Wednesday, January 12, 2010 at 2:45
pm PST
PETALUMA, Calif.--(BUSINESS WIRE)--
Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) today announced that
Hoji Alimi, the company's CEO and founder, will discuss the upcoming
2011 regulatory and commercial milestones during his presentation at the
OneMed Forum 2011 to be held at the Sir Francis Drake Hotel in San
Francisco, California. Mr. Alimi's presentation is scheduled on
Wednesday, January 12 at 2:45 pm PST, with a breakout session to
immediately follow.
To listen to the view the webcast, please visit www.ustream.tv/channel/onemedforum
at least 15 minutes early to download any necessary software.
Participation in the conference is by invitation only. For more
information on the conference, please contact OneMed at www.onemedplace.com.
About Oculus Innovative Sciences
Oculus Innovative Sciences is a commercial medical technology
company that designs, produces and markets safe and effective tissue
care products based upon the Microcyn® Technology platform, which
significantly reduces the need for antibiotics while reducing infections
and accelerating healing. The Microcyn Technology addresses the need for
improved solutions in multiple markets including dermatology, oral care,
cosmeceutical, wound care and others. It features a biocompatible,
shelf-stable solution that is currently commercialized in the United
States, Europe, India, China and Mexico and select Middle East countries
under various country specific regulatory clearances and approvals.
Several solutions derived from this platform have demonstrated, in a
variety of research and investigational studies, the ability to treat a
wide range of pathogens, including antibiotic-resistant strains of
bacteria (including MRSA and VRE), viruses, fungi and spores; increase
blood flow to the wound site; and reduce both inflammation and pain
while assisting in faster wound closure. The company's headquarters are
in Petaluma, California, with manufacturing operations in the United
States and Latin America. More information can be found at www.oculusis.com.
Oculus Innovative Sciences, Microcyn, Dermacyn and Vetericyn are
trademarks or registered trademarks of Oculus Innovative Sciences, Inc.
All other trademarks and service marks are the property of their
respective owners.
Oculus Innovative Sciences, Inc.
Dan McFadden,
425-753-2105
Director of Public and Investor Relations
dmcfadden@oculusis.com
Source: Oculus Innovative Sciences, Inc.
News Provided by Acquire Media
Print page |
Email page
| 
Download PDF
|
Add to briefcase